DSP Ultra Short Fund An open ended ultra-short term debt scheme investing in debt and money market securities such that the Macaulay duration of the portfolio is between 3 months and 6 months (please refer page no. 21 under the section “Where will the Scheme invest?” in the SID for details on Macaulay’s Duration) |
![]() |
![]() ![]() ![]() |
Enhanced cash fund
Suitable for investing surplus cash over short-term, alternative to on-demand deposits
Kedar Karnik
Total work experience of 13 years.
Managing this Scheme since
July 2016.
Ultra Short Duration
Jul 31, 2006
CRISIL Ultra Short Term Debt Index
Regular Plan | |
Growth: | ₹ 2657.7659 |
Direct Plan | |
Growth: | ₹ 2791.6823 |
₹ 2,540 Cr
₹ 2,576 Cr
Regular Plan : | 0.98% |
Direct Plan : | 0.30% |
0.35 years
> 3 months
2,540
Modified Duration | 0.34 years |
Yield To Maturity | 3.58% |
Portfolio Macaulay Duration@@ | 0.35 years |
Nil
Name of Instrument | Rating | % to Net Assets |
DEBT INSTRUMENTS | ||
BOND & NCD's | ||
Listed / awaiting listing on the stock exchanges | ||
✔ Housing Development Finance Corporation Limited | CRISIL AAA | 6.43 |
✔ REC Limited | CRISIL AAA | 5.99 |
✔ LIC Housing Finance Limited | CARE AAA | 5.29 |
Bajaj Finance Limited | CRISIL AAA | 3.15 |
Reliance Industries Limited | CRISIL AAA | 1.04 |
Small Industries Development Bank of India | CARE AAA | 0.83 |
Total | 22.73 | |
Government Securities (Central/state) | ||
✔ 8.12% GOI 10-12-2020 | SOV | 14.33 |
Total | 14.33 | |
MONEY MARKET INSTRUMENTS | ||
Certificate of Deposit | ||
✔ Small Industries Development Bank of India | CARE A1+ | 8.16 |
✔ Bank of Baroda | IND A1+ | 5.88 |
✔ Export-Import Bank of India | CRISIL A1+ | 5.86 |
✔ National Bank for Agriculture and Rural Development | IND A1+ | 5.24 |
Axis Bank Limited | ICRA A1+ | 3.91 |
Bank of Baroda | ICRA A1+ | 2.93 |
ICICI Bank Limited | ICRA A1+ | 2.34 |
National Bank for Agriculture and Rural Development | CRISIL A1+ | 0.97 |
Small Industries Development Bank of India | CRISIL A1+ | 0.97 |
Total | 36.26 | |
Commercial Papers | ||
Listed / awaiting listing on the stock exchanges | ||
✔ Reliance Industries Limited | CARE A1+ | 4.80 |
✔ Standard Chartered Investments and Loans (India) Limited | CRISIL A1+ | 4.09 |
HDFC Securities Limited | CRISIL A1+ | 3.87 |
National Bank for Agriculture and Rural Development | IND A1+ | 2.32 |
Housing Development Finance Corporation Limited | CRISIL A1+ | 1.74 |
National Bank for Agriculture and Rural Development | ICRA A1+ | 1.16 |
Export-Import Bank of India | CRISIL A1+ | 0.98 |
Larsen & Toubro Limited | CRISIL A1+ | 0.97 |
Total | 19.93 | |
TREPS / Reverse Repo Investments / Corporate Debt Repo | 11.70 | |
Total | 11.70 | |
Cash & Cash Equivalent | ||
Net Receivables/Payables | -4.95 | |
Total | -4.95 | |
GRAND TOTAL | 100.00 |
✔ Top Ten Holdings
DSP Ultra Short Fund erstwhile known as DSP Money Manger Fund
Notes: 1. All corporate ratings are assigned by rating agencies like CRISIL, CARE, ICRA, IND.
2. Pursuant to SEBI circular SEBI/HO/IMD/DF4/CIR/P/2019/102 dated September 24, 2019 read with
circular no. SEBI/HO/IMD/DF4/CIR/P/2019/41 dated March 22, 2019. Below are the details of the
securities in case of which issuer has defaulted beyond its maturity date.
Security | ISIN |
value of the security
considered under net
receivables (i.e. value
recognized in NAV in
absolute terms and as
% to NAV) (Rs.in lakhs) |
total amount
(including
principal and
interest) that
is due to the
scheme on that
investment (Rs.in lakhs) | |
0% IL&FS Transportation Networks Limited Ncd Series A 23032019 | INE975G08140 | 0.00 | 0.00% | 6,627.81 |
Performance (CAGR Returns in %) | ||||
1 m | 3 m | 6 m | 1 yr | |
2.97 | 3.67 | 5.33 | 5.59 |
An Open ended income Scheme,
seeking to generate returns
commensurate with risk from a
portfolio constituted of money
market securities and/or debt
securities.
There is no assurance that the
investment objective of the
Scheme will be realized.
This Scheme is suitable for investors who are seeking*
• Income over a short-term investment horizon
• Investment in money market and debt securities
* Investors should consult their financial advisors if in doubt whether the product is suitable for them.